Navigation Links
Aprecia Welcomes Don Wetherhold as Its Chief Executive Officer

MASON, Ohio, Nov. 11, 2013 /PRNewswire/ -- Aprecia Pharmaceuticals Company ("Aprecia" or "the company") announced today that it has selected Don Wetherhold to serve as the company's next chief executive officer.  Wetherhold previously served as senior vice president, long-term care at Omnicare, Inc.  Prior to his time at Omnicare, Wetherhold was Aprecia's corporate commercialization officer.

"We are thrilled to have Don back at Aprecia, and we look forward to the leadership he will bring to this role," said E. Thomas Arington, Aprecia's chairman.  "Don was instrumental in devising our commercialization strategy at Aprecia.  We are now preparing to file our first product, and we have two additional products in development.  The company is poised for commercial success, and Don's expertise and commitment certainly augment Aprecia's momentum.

"We also know that Don's extensive experience within the healthcare field will serve both him and the company well.  Furthermore, we highly value not only his experience and intelligence but also his character," Arington concluded.

"I'm excited to be back at Aprecia for a number of reasons, not the least of which is the rare opportunity to be the first at something and redefine a market—which is what our breakthrough 3DP product development and manufacturing system has the potential to do," stated Wetherhold.  "Aprecia's technology is being used to enhance the delivery of gold-standard pharmaceutical products, thereby improving treatment adherence for certain patient populations.  The company's vision is to make medicines easier to take, and Aprecia has made great strides toward that vision this past year." 

Wetherhold has 26 years of experience in the healthcare industry, including key management positions and leadership roles at Omnicare, Cardinal Health, Snyder Healthcare Sales, and Solvay Pharmaceuticals.  Prior to his first tenure with Aprecia in 2010, he served as Prasco Laboratories' senior vice president and general manager of Hampton Laine, Prasco's branded pharmaceutical business.

About Aprecia Pharmaceuticals Company – Aprecia is a unique specialty pharmaceutical company built upon an innovative 3DP (three-dimensional printing) technology and manufacturing system.  Aprecia is the first and only company in the world to utilize this technology to develop and manufacture pharmaceutical products at commercial scale. 

CONTACT: Jeff Zurcher
P 513.204.1200

SOURCE Aprecia Pharmaceuticals Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ALCOR Scientific Inc. Welcomes New COO
2. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
3. Cosmetic Dermatology of Orange County Welcomes Worlds Most Advanced Technology for Tattoo Removal
4. Connecticuts CURE network welcomes HLK, its first Chinese member company
5. PurThread Technologies Welcomes Life Sciences Veterans to CEO and Board Positions
6. PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
7. SkelRegen Welcomes Director of Scientific Affairs to Management Team
8. Chesapeake Urology Associates Welcomes Dr. Anup R. Shah
9. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
10. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
11. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... In an ... Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of ... and surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... announced that it has undertaken significant expansion of its current state of the ... is part of PharmaTech’s strategy to increase its manufacturing capacity as well as ...
Breaking Medicine News(10 mins):